Private Advisor Group’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-12,247
| Closed | -$174K | – | 2455 |
|
|
2024
Q3 | $174K | Buy |
12,247
+520
| +4% | +$7.39K | ﹤0.01% | 2248 |
|
|
2024
Q2 | $152K | Sell |
11,727
-847
| -7% | -$11K | ﹤0.01% | 2188 |
|
|
2024
Q1 | $175K | Sell |
12,574
-6,037
| -32% | -$83.9K | ﹤0.01% | 2141 |
|
|
2023
Q4 | $266K | Sell |
18,611
-443
| -2% | -$6.32K | ﹤0.01% | 1859 |
|
|
2023
Q3 | $295K | Buy |
19,054
+2,254
| +13% | +$34.9K | ﹤0.01% | 1627 |
|
|
2023
Q2 | $259K | Buy |
+16,800
| New | +$259K | ﹤0.01% | 1713 |
|
|
2023
Q1 | – | Sell |
-10,629
| Closed | -$166 | – | 2034 |
|
|
2022
Q4 | $166 | Buy |
10,629
+41
| +0.4% | +$1 | ﹤0.01% | 1536 |
|
|
2022
Q3 | $137K | Sell |
10,588
-159,479
| -94% | -$2.06M | ﹤0.01% | 1737 |
|
|
2022
Q2 | $2.39M | Buy |
170,067
+35,385
| +26% | +$497K | 0.02% | 663 |
|
|
2022
Q1 | $1.93M | Buy |
134,682
+42,439
| +46% | +$608K | 0.01% | 815 |
|
|
2021
Q4 | $1.26M | Sell |
92,243
-28,604
| -24% | -$390K | 0.01% | 1006 |
|
|
2021
Q3 | $1.98M | Buy |
120,847
+74,973
| +163% | +$1.23M | 0.01% | 886 |
|
|
2021
Q2 | $772K | Buy |
45,874
+11,745
| +34% | +$198K | 0.01% | 1190 |
|
|
2021
Q1 | $623K | Buy |
34,129
+11,576
| +51% | +$211K | 0.01% | 1197 |
|
|
2020
Q4 | $410K | Buy |
+22,553
| New | +$410K | ﹤0.01% | 1320 |
|
|
2020
Q3 | – | Sell |
-4,790
| Closed | -$86K | – | 3210 |
|
|
2020
Q2 | $86K | Buy |
+4,790
| New | +$86K | ﹤0.01% | 1801 |
|